Written by Klarity Editorial Team
Published: Apr 10, 2026

If you’ve been lying awake at 3 a.m. scrolling through your phone, wondering if there’s a way to get help for your insomnia without dragging yourself to yet another in-person doctor’s appointment, you’re not alone. Millions of Americans struggle with chronic sleep problems, and telehealth has emerged as a convenient solution—but can you actually get prescription sleep medication through a virtual visit?
The short answer is yes, in most cases. However, the details depend on where you live, what medication you need, and whether you’re working with a legitimate telehealth provider. This guide breaks down everything you need to know about accessing insomnia treatment online in 2025, from federal regulations to state-specific rules to what medications are available.
At the federal level, the Ryan Haight Act of 2008 created strict rules around prescribing controlled substances (like opioids, stimulants, and certain sleep medications) via the internet. The law originally required an in-person medical evaluation before any controlled substance could be prescribed through telemedicine.
Here’s the crucial distinction: The Ryan Haight Act only applies to controlled substances. Non-controlled insomnia medications—like trazodone or low-dose doxepin—have never been subject to federal in-person requirements. This means telehealth providers have always been able to legally prescribe these medications after a proper virtual evaluation.
When COVID-19 hit in March 2020, the DEA temporarily waived the in-person requirement for controlled substances, allowing providers to prescribe medications like Ambien (zolpidem) or Lunesta (eszopiclone) via telehealth. This waiver has been extended multiple times—most recently through December 31, 2025. What happens after that remains uncertain, though industry experts anticipate either another extension or new permanent rules that may require some form of in-person evaluation for ongoing controlled substance prescriptions.
Bottom line for 2025: Telehealth providers can prescribe both non-controlled and controlled sleep medications through the end of the year, though many platforms focus primarily on non-controlled options to avoid potential regulatory complications when the waiver eventually expires.
While federal law sets a baseline, each state has its own telehealth regulations that can be more restrictive. Here’s what you need to know about some of the most populous states:
California takes a progressive approach to telehealth. The state explicitly recognizes that a telehealth examination can meet the ‘good faith exam’ standard required before prescribing. There’s no requirement for an in-person visit before prescribing insomnia medications via video consultation.
California is even considering legislation (AB 1503) that would allow asynchronous evaluations (like detailed questionnaires) in some cases, though this hasn’t been finalized as of December 2025.
Texas allows telemedicine prescribing for insomnia medications, typically requiring two-way audio-video communication for new prescriptions. The state doesn’t mandate an in-person exam for non-controlled sleep medications, making telehealth access relatively straightforward.
Florida permits telehealth consultations to serve as the basis for prescribing insomnia medications. The state does have restrictions on prescribing Schedule II controlled substances (the most tightly regulated drugs) via telehealth, but this doesn’t affect most insomnia medications, which fall into lower schedules or aren’t controlled at all.
New York finalized rules in May 2025 addressing controlled substance prescribing via telehealth, implementing a 30-day supply limit for new prescriptions without an in-person exam. However, non-controlled insomnia medications remain fully accessible through telehealth without special restrictions.
A few states, like Alabama, require periodic in-person evaluations if you’re receiving ongoing care exclusively through telehealth. In Alabama, after four telehealth visits for the same condition within a year, you must have an in-person evaluation within 12 months. These rules apply to all telehealth care, not just insomnia treatment.
Other states, like New Hampshire, recently went the opposite direction—explicitly removing in-person requirements for telehealth prescribing as of August 2025.
Not all sleep medications are created equal when it comes to telehealth accessibility. Here’s what you should know:
Trazodone is an antidepressant commonly prescribed off-label for insomnia. It’s not a controlled substance, which means there are no federal supply limits or special restrictions. Telehealth providers can prescribe trazodone with refills, typically starting with a 30-day supply to assess how you respond, then providing longer-term prescriptions with periodic check-ins.
Doxepin (Silenor) at low doses is FDA-approved specifically for insomnia. Like trazodone, it’s unscheduled and can be prescribed via telehealth in all states. Initial prescriptions are usually for 30 days, with refills available after follow-up consultations.
Both medications require prescriptions—you can’t legally buy them without one—but they’re generally easier to obtain through telehealth than controlled substances because they carry lower abuse potential and face fewer regulatory hurdles.
Medications like Ambien (zolpidem), Lunesta (eszopiclone), and benzodiazepines are Schedule IV controlled substances. While the current federal waiver allows these to be prescribed via telehealth through 2025, many telehealth platforms avoid prescribing them for several reasons:
Reputable telehealth providers typically reserve controlled sleep medications for patients who’ve tried non-controlled options first or who have established relationships with the platform.
Licensed physicians can prescribe any appropriate insomnia medication via telehealth in states where they’re licensed, as long as they follow state-specific telehealth requirements.
Nurse practitioners’ prescribing authority varies significantly by state:
Independent practice states (like New Hampshire, New York after required experience, and increasingly California) allow NPs to evaluate and prescribe insomnia medications without physician oversight.
Collaborative practice states (like Texas, Florida, and Georgia) require NPs to work under physician protocols or supervision. However, they can still prescribe non-controlled insomnia medications—a supervising physician just needs to be nominally involved according to state requirements.
The trend nationally is toward expanded NP independence, with about 27 states now allowing full practice authority. This means more patients can access qualified providers through telehealth platforms that employ NPs.
PAs in all states can prescribe insomnia medications under appropriate physician supervision or collaboration agreements. The level of oversight varies by state, but PAs are authorized to prescribe non-controlled sleep medications in every state when working within their scope of practice.
A legitimate telehealth provider won’t simply hand out prescriptions. Expect a thorough evaluation that includes:
Sleep history: How long have you had insomnia? How many nights per week? What happens when you try to sleep?
Medical history: What other conditions do you have? What medications are you taking? Have you tried sleep medications before?
Lifestyle factors: What’s your caffeine and alcohol intake? What’s your bedtime routine? Do you exercise? What’s your stress level?
Red flag screening: Do you snore heavily? Do you have breathing pauses at night? Any chest pain, neurological symptoms, or severe daytime drowsiness?
Many providers will ask you to keep a sleep diary for a week or two before prescribing medication, which helps identify patterns and underlying causes.
Telehealth is excellent for primary insomnia and mild to moderate sleep problems, but certain situations require in-person evaluation:
Sleep apnea concerns: If you snore loudly, gasp for air at night, or have witnessed breathing pauses, you likely need a sleep study that can’t be done remotely.
Complex medical conditions: If your insomnia might be caused by untreated thyroid disease, severe depression, or other conditions requiring lab work or physical examination, your telehealth provider should refer you for in-person care.
Red flag symptoms: Chest pain, severe headaches, confusion, hallucinations, or symptoms suggesting a serious underlying condition require immediate in-person or emergency evaluation.
Medication-seeking behavior: If you’re specifically requesting potentially addictive controlled substances or showing patterns consistent with substance abuse, ethical providers will decline to prescribe and recommend appropriate resources.
Reputable telehealth platforms screen carefully for these situations and will direct you to in-person care when appropriate.
Here’s something important that distinguishes quality telehealth providers from prescription mills: good sleep medicine isn’t just about pills.
CBT-I is actually the first-line treatment recommended by sleep medicine experts for chronic insomnia. It’s a structured program that helps you identify and change thoughts and behaviors that interfere with sleep. Research shows CBT-I can be as effective as medication for many people, with longer-lasting results.
Many telehealth platforms—including Klarity Health—integrate behavioral approaches with medication management. This might include:
Medications are most helpful as a short-term solution while you work on behavioral changes, or for people with chronic insomnia that hasn’t responded to non-medication approaches. The goal is typically to use the lowest effective dose for the shortest necessary time, with periodic reassessments.
Once your provider prescribes medication, you’ll receive it just like any other prescription. In most states, providers are required to send prescriptions electronically to your chosen pharmacy. You can then pick it up or, in many cases, have it delivered.
Klarity Health accepts both insurance and cash pay options, with transparent pricing so you know costs upfront. Insurance coverage for telehealth has expanded significantly since 2020, with most plans now covering virtual visits at the same rate as in-person appointments.
For medications, coverage depends on your pharmacy benefits. Non-controlled generic insomnia medications like trazodone are usually well-covered and inexpensive even without insurance (often under $15 for a month’s supply).
Expect periodic follow-ups to monitor your response to treatment. For ongoing insomnia management, providers typically want to check in every 1-3 months. These follow-ups can be done via telehealth, making it convenient to adjust your treatment plan without taking time off work for appointments.
Some states (like New Hampshire) now explicitly require at least annual evaluations for ongoing telehealth prescribing, ensuring appropriate monitoring.
One advantage of telehealth is access to providers when you need them. Platforms like Klarity Health offer flexible appointment times, including evenings and weekends, which is particularly helpful when your work schedule makes daytime appointments difficult. With licensed providers in multiple states, you can usually connect with someone quickly rather than waiting weeks for an opening with a local sleep specialist.
The regulatory landscape for telehealth continues to evolve. While non-controlled insomnia medications are expected to remain accessible via telemedicine indefinitely, the future of controlled substance prescribing depends on pending DEA regulations.
The agency is expected to implement new rules in 2026 that may require:
However, bipartisan support exists in Congress for maintaining telehealth access, particularly for mental health and chronic disease management. Many healthcare organizations are advocating for permanent flexibilities that balance patient access with appropriate safeguards.
For patients seeking insomnia treatment, the key is working with established, reputable platforms that prioritize safety and compliance over simply handing out prescriptions.
If you’re considering telehealth for insomnia treatment, here are some tips to ensure you get quality care:
Choose a reputable platform: Look for services that employ licensed providers, conduct thorough evaluations, integrate behavioral approaches, and have clear policies about when in-person care is needed. Klarity Health’s model of combining accessible virtual care with evidence-based treatment protocols represents the standard you should expect.
Be honest and thorough: Provide complete information about your symptoms, medical history, and what you’ve tried before. This helps your provider develop the most effective treatment plan.
Keep a sleep diary: Tracking your sleep patterns, including when you go to bed, when you actually fall asleep, nighttime awakenings, and morning wake time, gives your provider valuable data.
Be patient with the process: Finding the right insomnia treatment sometimes takes trial and adjustment. What works for one person may not work for another.
Stay engaged with follow-up: Don’t just get a prescription and disappear. Regular check-ins help ensure your treatment remains effective and safe.
While telehealth is convenient for most insomnia situations, certain symptoms require urgent in-person evaluation:
If you experience any of these, contact your primary care provider immediately or go to an emergency room.
Yes, you can absolutely get insomnia medication through telehealth in 2025. Non-controlled medications like trazodone and low-dose doxepin are accessible via telemedicine in all states with no special restrictions beyond standard telehealth requirements. Controlled sleep medications are currently available through temporary federal waivers, though the future regulatory framework remains uncertain.
The key is choosing a provider that offers comprehensive care—not just prescriptions, but also evaluation for underlying causes, behavioral interventions, and appropriate follow-up. Telehealth for insomnia works best as part of a holistic approach to improving your sleep, combining the convenience of virtual care with evidence-based treatment.
If you’ve been putting off getting help for your insomnia because you can’t find time for in-person appointments, telehealth offers a legitimate, legal, and effective alternative. With providers available across multiple states, flexible scheduling, and both insurance and transparent cash-pay options, platforms like Klarity Health make it easier than ever to finally get the rest you need.
Ready to start sleeping better? Klarity Health offers convenient telehealth consultations with licensed providers who can evaluate your insomnia and develop a personalized treatment plan—often with same-week appointments. Visit our website to learn more about our approach to insomnia treatment and schedule your first consultation.
DEA.gov – ‘DEA and HHS Extend Telemedicine Flexibilities Through 2025’ (November 15, 2024). Official announcement from the Drug Enforcement Administration extending COVID-19 telehealth prescribing waivers for controlled substances through December 31, 2025. www.dea.gov
National Law Review – Sheppard Mullin LLP, ‘Telehealth and In-Person Visits: Tracking Federal and State Updates from the Pandemic Era’ (August 15, 2025). Comprehensive legal analysis of state-by-state telehealth prescribing regulations, including recent changes in New Hampshire, Delaware, New York, Texas, and California. natlawreview.com
Center for Connected Health Policy (CCHP) – ‘Online Prescribing State Laws’ (Updated November 2025). Authoritative compilation of state telehealth prescribing requirements, including specific provisions for controlled and non-controlled substances across all U.S. states. www.cchpca.org/topic/online-prescribing
Healthcare Finance News – Susan Morse, ‘Telehealth Prescribing of Controlled Drugs Extended Through 2025’ (November 18, 2024). Healthcare industry reporting on the third DEA extension of pandemic-era telehealth flexibilities, with context on previous extensions and regulatory timeline. www.healthcarefinancenews.com
Texas Board of Nursing – ‘APRN Frequently Asked Questions’ (Accessed December 2025). Official guidance from Texas regulatory authority on nurse practitioner and physician assistant prescribing authority, including scope of practice for controlled and non-controlled substances. www.bon.texas.gov/faqpracticeaprn.asp.html
Find the right provider for your needs — select your state to find expert care near you.